A novel autoinflammatory skin disease in a patient with mutations in alpha-T-catenin
α-T-连环蛋白突变患者的一种新型自身炎症性皮肤病
基本信息
- 批准号:10055124
- 负责人:
- 金额:$ 23.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-17 至 2022-05-31
- 项目状态:已结题
- 来源:
- 关键词:10 year oldActin-Binding ProteinActinsAffectAffinityAnatomyArchitectureArrhythmiaArrhythmogenic Right Ventricular DysplasiaBacteriaBinding ProteinsBiochemistryBiological ProcessBiologyBiopsy SpecimenBloodCRISPR/Cas technologyCadherinsCell LineCell-Cell AdhesionCellsChildComplexCultured CellsCytoskeletonDataDiseaseEnvironmentEyeEyelid structureFeverFunctional disorderGene ExpressionGenesGeneticGlandGrowthHair follicle structureHeartHeart DiseasesHereditary DiseaseHomodimerizationHost DefenseHumanHyperkeratosisImmuneImmune systemImmunityImmunologicsImpairmentInfection preventionInflammationInflammatoryIntercalated discInterferon Type IInterferonsKnowledgeLeadLifeLigandsLinkLipidsMapsMeasuresMediatingMissense MutationMucous MembraneMusMutagenesisMutationNonsense CodonNutrientOcular PathologyOrganOrganismPatientsPatternPhenotypeProductionProteinsRecombinantsRecording of previous eventsRecurrenceReporterReportingSebaceous GlandsSebumSiteSkinSkin colonizationSterilityStructureSystemTestingTissuesUp-RegulationViralalpha cateninalphaT cateninantimicrobial peptideappendageautoinflammatorybeta cateninboyschemokinecohesioncommensal microbescytokinegenetic signaturehuman diseaseimmunomodulatory therapiesimprovedin vitro testinginsightkeratinocytelink proteinmeibomian gland dysfunctionmetagenomic sequencingmutantnovelpathogenprematureprotein functionskin barrierskin disorderskin microbiomeskin microbiotastemthree dimensional cell culture
项目摘要
Abstract
Inborn errors of immunity comprise over 300 distinct disorders. Among these are an expanding number of
monogenic auto-inflammatory disorders, characterized by sterile inflammation systemically or in specific
organs. This proposal stems from the identification of a child who appears to have a novel autoinflammatory
disease characterized by inflammatory skin disease and associated with increased type I interferon production
but without recurrent fever. This patient has compound heterozygous mutations in the gene encoding αT-
catenin: CTNNA3. The α-catenins are actin-binding proteins that interact with cadherins to mediate cell-cell
adhesion and tissue organization. Different mutations in CTNNA3 are linked with a specific cardiac disease in
humans, arrhythmogenic right ventricular dysplasia, but this child does not have cardiac disease. Importantly,
there are no prior associations of mutations in CTNNA3 with inflammatory skin disease. Here we seek to
understand how this patient’s mutant αT-catenin drives skin inflammation and increased type I interferon
production. Our preliminary data demonstrate that αT-catenin is highly expressed in sebaceous glands in
healthy human skin. The skin serves as a barrier between an organism and the surrounding environment. Hair
follicles breach this anatomic barrier and provide a potential portal of entry for pathogens; they are thus a site
of much immunologic activity. Anatomically associated with hair follicles, sebaceous glands secrete lipids that
contribute to skin barrier function and serve as nutrients for commensal microbiota. Sebaceous glands also
produce antimicrobial peptides, cytokines, and chemokines to modulate skin immunity. Mice lacking
sebaceous glands develop a phenotype similar to this patient. The central hypothesis of this proposal is that
αT-catenin is critical for normal sebaceous gland function. Further, we propose that this patient’s CTNNA3
mutations disrupt αT-catenin function, altering sebaceous gland activity and culminating in inflammatory skin
disease. We will first determine how this patient’s CTNNA3 mutations affect the fundamental biology of αT-
catenin, its association with binding proteins, and its subcellular localization. Next we will characterize how the
mutant αT-catenin affects sebaceous gland structure and function, using a combination of patient skin biopsy
samples and cultured human sebaceous gland cells (sebocytes). Finally, we will test the hypothesis that the
increased type I interferon signature in this patient stems either from a direct effect on skin cells or indirectly
through effects of altered sebaceous gland activity on the skin flora. The proposed studies will allow us to
characterize a novel autoinflammatory skin disease and the first human disease associated with reduced
sebaceous gland function; they may also provide insight to improve treatment of this patient’s skin disease.
Additionally, we will gain new knowledge of how the skin and its appendages (e.g. sebaceous glands) interface
with the environment, the immune system, and commensals to provide sophisticated barrier immunity.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bryce Binstadt其他文献
Bryce Binstadt的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bryce Binstadt', 18)}}的其他基金
A novel autoinflammatory skin disease in a patient with mutations in alpha-T-catenin
α-T-连环蛋白突变患者的一种新型自身炎症性皮肤病
- 批准号:
10197026 - 财政年份:2020
- 资助金额:
$ 23.68万 - 项目类别:
Pathogenesis of autoimmune valvular carditis
自身免疫性瓣膜性心脏病的发病机制
- 批准号:
10624894 - 财政年份:2014
- 资助金额:
$ 23.68万 - 项目类别:
Pathogenesis of autoimmune valvular carditis
自身免疫性瓣膜性心脏病的发病机制
- 批准号:
9815721 - 财政年份:2014
- 资助金额:
$ 23.68万 - 项目类别:
Macrophages as effectors of autoimmune valvular carditis
巨噬细胞作为自身免疫性瓣膜性心脏病的效应器
- 批准号:
9086419 - 财政年份:2014
- 资助金额:
$ 23.68万 - 项目类别:
Macrophages as effectors of autoimmune valvular carditis
巨噬细胞作为自身免疫性瓣膜性心脏病的效应器
- 批准号:
8754860 - 财政年份:2014
- 资助金额:
$ 23.68万 - 项目类别:
Pathogenesis of autoimmune valvular carditis
自身免疫性瓣膜性心脏病的发病机制
- 批准号:
10418653 - 财政年份:2014
- 资助金额:
$ 23.68万 - 项目类别:
Macrophages as effectors of autoimmune valvular carditis
巨噬细胞作为自身免疫性瓣膜性心脏病的效应器
- 批准号:
8890874 - 财政年份:2014
- 资助金额:
$ 23.68万 - 项目类别:
Pathogenesis of autoimmune valvular carditis
自身免疫性瓣膜性心脏病的发病机制
- 批准号:
9926159 - 财政年份:2014
- 资助金额:
$ 23.68万 - 项目类别:
相似海外基金
STRUCTURE/INTERACTIONS OF ACTINS AND ACTIN-BINDING PROTEIN
肌动蛋白和肌动蛋白结合蛋白的结构/相互作用
- 批准号:
6316669 - 财政年份:2000
- 资助金额:
$ 23.68万 - 项目类别:
STRUCTURE/INTERACTIONS OF ACTINS AND ACTIN-BINDING PROTEIN
肌动蛋白和肌动蛋白结合蛋白的结构/相互作用
- 批准号:
6338828 - 财政年份:2000
- 资助金额:
$ 23.68万 - 项目类别:
STRUCTURE/INTERACTIONS OF ACTINS AND ACTIN-BINDING PROTEIN
肌动蛋白和肌动蛋白结合蛋白的结构/相互作用
- 批准号:
6107703 - 财政年份:1999
- 资助金额:
$ 23.68万 - 项目类别:
STRUCTURE/INTERACTIONS OF ACTINS AND ACTIN-BINDING PROTEIN
肌动蛋白和肌动蛋白结合蛋白的结构/相互作用
- 批准号:
6271817 - 财政年份:1998
- 资助金额:
$ 23.68万 - 项目类别:
STRUCTURE/INTERACTIONS OF ACTINS AND ACTIN-BINDING PROTEIN
肌动蛋白和肌动蛋白结合蛋白的结构/相互作用
- 批准号:
6240599 - 财政年份:1997
- 资助金额:
$ 23.68万 - 项目类别:
STRUCTURE/INTERACTIONS OF ACTINS & ACTIN-BINDING PROTEIN
肌动蛋白的结构/相互作用
- 批准号:
3287441 - 财政年份:1985
- 资助金额:
$ 23.68万 - 项目类别:
STRUCTURE/INTERACTIONS OF ACTINS & ACTIN-BINDING PROTEIN
肌动蛋白的结构/相互作用
- 批准号:
3287442 - 财政年份:1985
- 资助金额:
$ 23.68万 - 项目类别:
STRUCTURE/INTERACTIONS OF ACTINS & ACTIN-BINDING PROTEIN
肌动蛋白的结构/相互作用
- 批准号:
3287445 - 财政年份:1985
- 资助金额:
$ 23.68万 - 项目类别:
STRUCTURE/INTERACTIONS OF ACTINS & ACTIN-BINDING PROTEIN
肌动蛋白的结构/相互作用
- 批准号:
3287439 - 财政年份:1985
- 资助金额:
$ 23.68万 - 项目类别:
STRUCTURE/INTERACTIONS OF ACTINS & ACTIN-BINDING PROTEIN
肌动蛋白的结构/相互作用
- 批准号:
3287443 - 财政年份:1985
- 资助金额:
$ 23.68万 - 项目类别:














{{item.name}}会员




